Pulmonary hypertension (PH) is a relatively common complication of left-heart disease and represents a challenging clinical situation for providers and patients alike. The aging demographic in the United States and widespread use of echocardiography in these patients often results in a consult to evaluate the PH. Unfortunately, proven treatment options are limited. Regardless, there is a critical need for PH experts to have a thorough understanding of the pathophysiology, clinical presentations and most appropriate management recommendations. The current issue offers the opportunity to review all of those issues in detail.
—Charles D. Burger, MD, Editor-in-Chief
Advances in Pulmonary Hypertension, Vol. 14, No. 2
Pulmonary Hypertension and Left Heart Disease
- Editor's Memo
- Guest Editor's Memo
- Research Reviews
- Overview of WHO Group 2 PH Due to Left Heart Disease
- The Right Ventricle: A Not-So-Innocent Bystander in PH Due to Left Heart Disease
- PH Due to Heart Failure With Preserved Ejection Fraction: Clinical Relevance, Management, and Future Directions
- PH Due to Valvular Heart Disease: Aortic and Mitral
- Ask the Expert: Is Cardiac Magnetic Resonance Imaging Underutilized in the Diagnosis of PH?
- PH Roundtable: PH Due to Left Heart Disease